Investigational New Drugs,volume 27,issue 2  (04-2014)

Period of time: 2014年2期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 27,issue 2

Menu

Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer

By Buijs Manon,Vossen Josephina,Geschwind Jean-Francois,Ishimori Takayoshi,Engles James,Acha-Ngwodo Obele,Wahl Richard,Vali Mustafa in (2009)

Investigational New Drugs,volume 27,issue 2 , Vol. 27, Iss. 2, 2009-04 , pp. 120-123

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Application of population pharmacokinetic modeling in early clinical development of the anticancer agent E7820

By Keizer Ron,Zamacona Miren,Jansen Mendel,Critchley David,Wanders Jantien,Beijnen Jos,Schellens Jan,Huitema Alwin in (2009)

Investigational New Drugs,volume 27,issue 2 , Vol. 27, Iss. 2, 2009-04 , pp. 140-152

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies

By Sayar H.,Shen Z.,Lee S.,Royce M.,Rabinowitz I.,Lee F.,Smith H.,Eberhardt S.,Maestas A.,Lu H.,Verschraegen C. in (2009)

Investigational New Drugs,volume 27,issue 2 , Vol. 27, Iss. 2, 2009-04 , pp. 153-158

Springer Publishing Company

Abstract Access to resources Recommend Favorite